Urokinase use was lower for Palindrome than for HemoStar , as evidenced by a lower number of urokinase infusions/1 ,000 catheter-days ( 17 and 35 ; P < 0.001 ) and higher number of catheters that never required thrombolysis ( 58 % and 45 % ; P = 0.03 ) .